Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tredaptive effects on lipoproteins and oxidative stress markers in hypercholesterolaemia
2010-018531-17Phase 4Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of laropiprant in hypercholesterolemia, sponsored by Manchester University NHS Foundation Trust. Primary endpoint: HDL increase. Started Mar 2010; status: completed.
02
Drugs
laropiprant
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on 2010-018531-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018531-17.